Table 1 Demographic and clinical characteristics of patients with rheumatoid arthritis and psoriatic arthritis

Age, years

65 [51–74]

56 [44–74]

Sex, male/female

15/114

24/29

DAS28-ESR

5.97 [4.99–6.71]

5.50 [4.05–6.78]

DAS28-ESR 2.6–5.1/DAS28-ESR >5.1, %

25.0%/75.0%

41.8%/58.2%

CDAI

37.0 [24.0–44.1]

33.6 [14.0–52.1]

Disease duration, years

18.5 [9.0–29.0]

14.0 [8.0–30.0]

ESR, mm/h

27.5 [19.0–39.5]

14.5 [4.0–46.5]

CRP, mg/L

11.9 [4.8–24.5]

2.7 [0.7–29.1]

RF, IU/L

79.7 [15.0–239.0]

N/A

ACPA, EU/L

68.7 [2.2–270.8]

N/A

Tender joint count (out of 28)

15 [8–22]

17 [3–26]

Swollen joint count (out of 28)

7 [2–12]

6 [0–14]

Disease activity, cm, physician’s VAS assessment

7.0 [5.5–8.8]

6.4 [4.7–9.0]

Disease activity, cm, patient’s VAS assessment

7.0 [5.0–8.8]

6.9 [4.9–8.2]